[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA200107110B - Medicament for treating diabetes. - Google Patents

Medicament for treating diabetes.

Info

Publication number
ZA200107110B
ZA200107110B ZA200107110A ZA200107110A ZA200107110B ZA 200107110 B ZA200107110 B ZA 200107110B ZA 200107110 A ZA200107110 A ZA 200107110A ZA 200107110 A ZA200107110 A ZA 200107110A ZA 200107110 B ZA200107110 B ZA 200107110B
Authority
ZA
South Africa
Prior art keywords
enzyme mixtures
pancreatin
digestive enzyme
treatment
medicament
Prior art date
Application number
ZA200107110A
Other languages
English (en)
Inventor
Sander-Struckmeier Suntje
Claus Rudolf Steinborn
Martin A Rudmann
Diethard Schwanitz
Friederike Henniges
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of ZA200107110B publication Critical patent/ZA200107110B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA200107110A 1999-03-17 2001-08-28 Medicament for treating diabetes. ZA200107110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19911778 1999-03-17

Publications (1)

Publication Number Publication Date
ZA200107110B true ZA200107110B (en) 2002-10-30

Family

ID=7901217

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107110A ZA200107110B (en) 1999-03-17 2001-08-28 Medicament for treating diabetes.

Country Status (23)

Country Link
US (1) US7122357B2 (xx)
EP (1) EP1162995B1 (xx)
JP (1) JP4938174B2 (xx)
CN (1) CN1221284C (xx)
AT (1) ATE242003T1 (xx)
AU (1) AU773930B2 (xx)
BR (1) BR0009012A (xx)
CA (1) CA2367355C (xx)
CZ (1) CZ20013345A3 (xx)
DE (2) DE50002450D1 (xx)
DK (1) DK1162995T3 (xx)
ES (1) ES2194720T3 (xx)
HK (1) HK1044477B (xx)
HU (1) HUP0200556A3 (xx)
NO (1) NO20014507D0 (xx)
NZ (1) NZ514826A (xx)
PL (1) PL199180B1 (xx)
PT (1) PT1162995E (xx)
RU (1) RU2268065C2 (xx)
SK (1) SK284677B6 (xx)
TR (1) TR200102784T2 (xx)
WO (1) WO2000054799A2 (xx)
ZA (1) ZA200107110B (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7020384B1 (en) 1999-08-12 2006-03-28 Lg Electronics Inc. Method for creating and recording transport time information for data recorded on a disk
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8100844B2 (en) * 2002-04-25 2012-01-24 Ultraflex Systems, Inc. Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
US7519274B2 (en) 2003-12-08 2009-04-14 Divx, Inc. File format for multiple track digital data
ATE407693T1 (de) 2004-03-22 2008-09-15 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin,mit tensiden
RU2389504C2 (ru) * 2004-05-24 2010-05-20 Новозимс А/С Ферменты для фармацевтического применения
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
CA2612806A1 (en) * 2005-06-24 2006-12-28 Solvay Pharmaceuticals Gmbh Proteases for pharmaceutical use
NZ563693A (en) * 2005-06-24 2010-08-27 Novozymes As Lipases derived from Thermocyces lanuginosus optionally in combination with a protease and/or amylase for pharmaceutical use
WO2006136161A2 (en) * 2005-06-24 2006-12-28 Novozymes A/S Amylases for pharmaceutical use
RU2413532C2 (ru) * 2005-07-29 2011-03-10 Зольвай Фармасьютиклз Гмбх Способ получения стерилизованного порошкообразного панкреатина
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
NZ565959A (en) * 2005-08-15 2011-10-28 Solvay Pharm Gmbh Pancreatin micropellet cores suitable for enteric coating
JP5284092B2 (ja) * 2005-08-15 2013-09-11 アボット ラボラトリーズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 腸溶コーティングに適したパンクレアチンマイクロペレットコア
DK1931316T4 (en) 2005-08-15 2017-05-15 Abbott Laboratories Gmbh Controlled-release pharmaceutical compositions for use in acid-labile drugs
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US8071089B2 (en) * 2005-11-01 2011-12-06 Bio-Cat, Inc. Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2261328B1 (en) * 2006-12-21 2013-11-20 Novozymes A/S Lipase variants for pharmaceutical use
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US8455235B2 (en) 2007-12-04 2013-06-04 Novozymes A/S Protease variants for pharmaceutical use
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
GB2465814B (en) * 2008-06-19 2011-10-26 Tarig Sayed Mustafa Arbab Method,composition and device for the treatment of enzymes and saccharides disorders
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
ES2732453T3 (es) 2008-07-01 2019-11-22 Curemark Llc Métodos y composiciones para el tratamiento de síntomas de trastornos neurológicos y de salud mental
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
GB2480773B (en) 2009-01-06 2013-12-11 Curelon Llc Compositions for the treatment of diarrhea caused by virulent E. coli infections
US9107419B2 (en) 2009-01-06 2015-08-18 Curelon Llc Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
EP2566466A1 (en) * 2010-05-03 2013-03-13 Aptalis Pharma Limited Micropellet compositions comprising pancreatin containing digestive enzyme mixtures
JP5976100B2 (ja) 2011-04-21 2016-08-23 キュアマーク リミテッド ライアビリティ カンパニー 神経精神障害の処置のための化合物
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
WO2013155476A1 (en) * 2012-04-12 2013-10-17 Integrative Enzymatics, Inc. Composition and method for modulating inflammatory molecules with amylase
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
EP3685661A4 (en) * 2017-09-19 2021-05-19 Meiji University PROCESS FOR DEVELOPMENT OF AN ORGAN LACKING A SPECIFIC FUNCTIONAL CELL
CN109142728A (zh) * 2018-09-04 2019-01-04 深圳市鸿美诊断技术有限公司 一种定量测定粪便中胰弹性蛋白酶1的试剂盒及其应用
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803305A (en) * 1962-12-28 1974-04-09 Rolland A Lab Process for obtaining extracts from pancreas
DE2512746C3 (de) 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin
SU908352A1 (ru) * 1980-02-11 1982-02-28 Винницкий Областной Госпиталь Для Инвалидов Отечественной Войны Способ лечени гнойных ран
DE4203315A1 (de) 1991-02-14 1992-08-20 Kali Chemie Pharma Gmbh Verfahren zur gewinnung von pankreatin
US5614224A (en) * 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics

Also Published As

Publication number Publication date
CA2367355C (en) 2012-06-05
NO20014507L (no) 2001-09-17
NZ514826A (en) 2003-08-29
SK12852001A3 (sk) 2002-02-05
DE50002450D1 (de) 2003-07-10
PL350627A1 (en) 2003-01-27
SK284677B6 (sk) 2005-09-08
JP2002539173A (ja) 2002-11-19
PL199180B1 (pl) 2008-08-29
JP4938174B2 (ja) 2012-05-23
AU773930B2 (en) 2004-06-10
WO2000054799A2 (de) 2000-09-21
US7122357B2 (en) 2006-10-17
EP1162995A2 (de) 2001-12-19
WO2000054799A3 (de) 2001-04-26
EP1162995B1 (de) 2003-06-04
CA2367355A1 (en) 2000-09-21
ES2194720T3 (es) 2003-12-01
HK1044477A1 (en) 2002-10-25
TR200102784T2 (tr) 2002-04-22
CN1343126A (zh) 2002-04-03
PT1162995E (pt) 2003-08-29
HUP0200556A2 (en) 2002-06-29
DK1162995T3 (da) 2003-06-23
DE10012095A1 (de) 2000-09-21
NO20014507D0 (no) 2001-09-17
RU2268065C2 (ru) 2006-01-20
HK1044477B (zh) 2006-02-03
HUP0200556A3 (en) 2006-06-28
BR0009012A (pt) 2001-12-26
AU4395000A (en) 2000-10-04
CN1221284C (zh) 2005-10-05
US20020061302A1 (en) 2002-05-23
CZ20013345A3 (cs) 2002-01-16
ATE242003T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
HK1044477A1 (en) Medicament for treating diabetes
RU2001126526A (ru) Лекарственное средство, предназначенное для лечения диабета
HK1060045A1 (en) Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleepdisturbances
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
FI925787A (fi) Proteolytiska enzymers sackarinderivatinhibitorer
JP2002539173A5 (xx)
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
HUP0500560A2 (hu) Mikróbás enzimek új keverékei
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
RU2006145899A (ru) Ферменты для фармацевтического применения
IL114641A (en) Pharmaceutical compositions containing dispersible fluoxetine
BR0111989A (pt) Peptìdeos, composições e processos para o tratamento de burkholderia cepacia
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
TR200101980T2 (tr) Arilalkanoil türevleri, bunların preparasyon işlemleri
WO2003056897A3 (en) Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease
IL153182A0 (en) Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
ATE258229T1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
MXPA04006457A (es) Alcanosulfonamidas novedosas como antagonistas de endotelina.
YU31902A (sh) Polipeptidna kompozicija
LT2002105A (en) Novel use of siberian fir oil
GEP20033130B (en) Inhibitors of IMPDH Enzyme